MedPath

Panagen, Limited Liability Company

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: Placebo
Procedure: Chemotherapy
First Posted Date
2014-04-16
Last Posted Date
2014-07-15
Lead Sponsor
Panagen, Limited Liability Company
Target Recruit Count
80
Registration Number
NCT02115984

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.